Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Application of myricanol in preparing drug for resisting virulence of Gram-negative bacteria

A gram-negative bacteria, anti-bacterial technology, applied in the field of natural medicinal chemistry and pharmaceutical applications, can solve the problem of no relevant reports on the material basis of medicinal effects

Active Publication Date: 2019-07-09
SHANDONG UNIV
View PDF1 Cites 5 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0007] Myrica esculenta Buchanan-Hamilton ex D.Don, the root bark and bark of Myrica esculenta Buchanan-Hamilton ex D.Don, is used in Dai medicine and Dai medicine to connect Luduan, Mengshahe and Xiole (that is, red and white dysentery, abdominal pain and diarrhea), but there is no relevant report on the material basis of its pharmacodynamics

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of myricanol in preparing drug for resisting virulence of Gram-negative bacteria
  • Application of myricanol in preparing drug for resisting virulence of Gram-negative bacteria
  • Application of myricanol in preparing drug for resisting virulence of Gram-negative bacteria

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0026] Example 1. Separation of myricanol (myricanol)

[0027] Myricanol (myricanol) is separated from the dry bark of Chinese bayberry, and the separation method is as follows:

[0028] (1) Weigh 1.0 kg of dry bark of Bayberry, crushed and soaked in ethyl acetate for 3 times, extracted for two days each time, combined the extracts, and concentrated to dryness under reduced pressure at 40°C to obtain a crude extract;

[0029] (2) The crude extract is dissolved in water, and the total extract is sequentially extracted with petroleum ether, ethyl acetate and methanol, and the petroleum ether component, ethyl acetate component and methanol component are obtained after the solvent is recovered;

[0030] (3) The test results of anti-Salmonella T3SS activity show that the methanol component has better activity to inhibit the secretion of Salmonella virulence protein, so the methanol component is separated. First, it was chromatographed on Sephadex LH-20 gel column and eluted with methanol t...

Embodiment 2

[0031] Example 2. Structural identification of myricanol (myricanol)

[0032] Compound 1: ESI-MS measured the quasi-molecular ion peak of Compound 1 of Example 1 as m / z 359.2 [M+H] + ; White amorphous powder; 1 H, 13 C NMR and HMQC spectra show that the compound has 21 carbon atoms, including 12 sp 2 Hybrid olefinic carbon, 6 sp 3 Hybrid methine carbon, 1 sp 3 Hybrid methylene carbon atom and 2 methyl carbons. 1 H NMR data shows that the structure contains a tri-substituted benzene ring and a 5-substituted benzene ring, according to 1 H- 1 H COSY and HMQC determined the direct correlation between C-H; further through the long-range correlation between HMBC key protons and related carbons, it was determined that the structure of compound 1 is a cyclic diarylheptane compound myricanol (myricanol). The NMR data are as follows, 13 CNMR(400MHz, in acetone-d 6 ): δ125.0(C-1), 123.6(C-2), 147.6(C-3), 140.4(C-4), 149.8(C-5), 123.9(C-6), 26.3(C- 7), 26.5(C-8), 23.8(C-9), 40.4(C-10), 35.5(C...

Embodiment 3

[0033] Example 3. Inhibition of myricanol on the secretion of SipA, B, C and D of Salmonella type III virulence protein in vitro

[0034] Test principle:

[0035] The type III secretion system is a very important virulence factor in the pathogenic process of gram-negative bacteria. It uses the type III secretion system to secrete virulence proteins to promote the adhesion and invasion of host cells, as well as the reproduction and spread of the host cells. . Therefore, blocking the secretion of virulence proteins can inhibit the invasion of host cells by Gram-negative pathogens. In this experiment, Salmonella typhimurium UK-1 (χ8956) was used as the research object. Through the temperature induction method, Salmonella typhimurium secreted virulence proteins into the culture medium through the type III secretion system, and detected by SDS-PAGE and Western Blot. To evaluate the inhibitory effect of myricanol on the secretion of virulence proteins.

[0036] Test materials:

[0037] S...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to application of myricanol in preparing a drug for resisting bacterial virulence. The structural formula of a compound 1 is shown in the description. The myricanol is a diarylheptanoids compound, and has a function of significantly inhibiting the secretion of virulence proteins of a salmonella type III secretion system (T3SS). The inhibitor does not inhibit the growth of salmonella, but inhibits the invasion of host cells by the salmonella, and therefore the compound can be used for preparing the drug for resisting the virulence of Gram-negative bacteria.

Description

Technical field [0001] The invention relates to the application of a novel gram-negative bacterial virulence factor inhibitor, in particular to the application of compound myricanol (myricanol) in the preparation of anti-gram-negative bacterial virulence drugs, and belongs to the technical field of natural medicinal chemistry and medical applications. Background technique [0002] While antibiotics are treating infectious diseases, more and more drug-induced diseases and drug resistance have been produced, posing a huge threat to public health. Therefore, it is urgent to find new ways to resolve these crises and challenges. In addition, broad-spectrum antibiotics not only inhibit pathogenic microorganisms, but also inhibit physiological microorganisms in the human body, disrupt the normal pattern of flora or communities in the microbial ecosystem, and destroy the physiological function and health of the human body. Therefore, how to ensure the inhibitory effect of drugs on drug-...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/09C07C41/34C07C43/23A61P31/04
CPCA61K31/09A61P31/04C07C41/34C07C43/23Y02A50/30
Inventor 鲁春华沈月毛吴杨
Owner SHANDONG UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com